Gilead Sciences
GILD
GILD
1,325 hedge funds and large institutions have $139B invested in Gilead Sciences in 2014 Q3 according to their latest regulatory filings, with 126 funds opening new positions, 465 increasing their positions, 614 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,325
Holders Change
+64
Holders Change %
+5.08%
% of All Funds
38.47%
Holding in Top 10
240
Holding in Top 10 Change
+76
Holding in Top 10 Change %
+46.34%
% of All Funds
6.97%
New
126
Increased
465
Reduced
614
Closed
51
Calls
$2.53B
Puts
$3.96B
Net Calls
-$1.43B
Net Calls Change
-$802M
Top Buyers
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$245M |
| 2 |
D.E. Shaw & Co
New York
|
+$242M |
| 3 |
Barclays
London,
United Kingdom
|
+$198M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$192M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$155M |
Top Sellers
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$1.65B |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$1.29B |
| 3 |
Goldman Sachs
New York
|
-$1.27B |
| 4 |
Norges Bank
Oslo,
Norway
|
-$989M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$860M |
